Vigilance begins probe into alleged irregularities at Oushadhi
The Vigilance and Anti-Corruption Bureau has launched a preliminary inquiry into financial irregularities at Oushadhi, a state-run pharmaceutical firm. The probe follows a request from the Health Minister after audit reports and complaints highlighted potential operational misconduct.
Why it matters
Investigating financial irregularities in public sector undertakings is essential for maintaining transparency and accountability in state-managed health institutions.
The Vigilance and Anti-Corruption Bureau (VACB) has begun its preliminary enquiry into allegations of financial irregularities at Oushadhi, a public sector pharmaceutical firm under the Department of AYUSH.
Health Minister K. Muraleedharan had earlier written to the Home Minister, seeking a preliminary VACB enquiry into the allegations against Oushadhi, following damning audit reports on the firm as well as other complaints of financial and operational irregularities he had received from various individuals
Mr. Muraleedharan had also directed the Principal Secretary (Health) to initiate a detailed inquiry through the Finance Inspection Wing into the alleged financial irregularities at Oushadhi
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in